PPT-Efalizumab Subcutaneous injection

DB00095 DESCRIPTION Humanized IgG1 kappa isotype monoclonal antibody that binds to human CD11a Efalizumab has a molecular weight of approximately 150 kilodaltons and is produced in a Chinese hamster ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin. &#x/Att;¬he; [/;ott;&#xom ];&#x/BBo;&#xx [7; 35;&#x.730; 34;.77; 76;&#x.642; ]/;&#xSubt;&#xype ;&#x/Foo;&#xter ;&#x/Typ; /P; gin; tio;&#xn 00;&#x/Att;¬ administration Common sites used Common subcutaneous sites are a constant; that is, where there is a large deposition of subcutaneous fat under the skin. However, the selection of the site will vary Injection of substance directly in muscle, for forms of medicine used delivered in small amounts. Indications: . Where IV administration is not available.. Drugs with specific actions on muscles.. A longer half life is needed eg. Morphine for anaesthesia. majority of patients prescribed epinephrine auto injectors H obbins S, Johnstone J, O’Hickey S. Respiratory Department Worcestershire Royal Hospital, UK National Pollen & Aerobiology Resea Do not use for the treatment of acute bronchospasm or status asthmaticus. (5.3) For Horse, Cattle, Sheep, and Goats. What types of injections are there?. Subcutaneous . “SubQ”. What is a subcutaneous injection?. An injection given in the fatty layer of tissue just under the skin.. Principles of Injections. 12/12/2012. 2. Follow your veterinarians . guidleines. for all injections. Choose an area of clean, dry skin as the site for the injection.. Routes of Administration. 12/12/2012. 151 Dres. Cristián Varela U(1), Paulina Sepúlveda P(2), J. Prieto R(3), Sebastián Pavanati C(4)1.Radiologist. Head of Imaging Department, Clínica Dávila. Santiago – Chile. Research Fellow. I TREATING ALLERGY WITH ALLERGEN IMMUNOTHERAPYGoal Treat causes of allergy.Approach To get the immune system accustomed to allergens.Impact Alleviate discomfort. Prevent disease progression and emer-gen Injection. s. Percutaneous . introduction of a medicinal substance, fluid or nutrient into the body. (e. g. intradermal, subcutaneous, intramuscular, . intravenous). Syringe . Needle . Unsafe Use of Injections . GANGREN. By . Dr. Hussein . AlNaji. ETIOLOGY. Extensive accumulation of edema fluid in the subcutaneous tissue is part of general edema and is caused by the same diseases, as follows.. A-Increased Hydrostatic Pressure. DB09302. Description. :. Alirocumab. is a biopharmaceutical drug approved by the FDA in July 2015 as a second line treatment for high cholesterol for adults whose LDL-cholesterol (LDL-C) is not controlled by diet and statin treatment. It is a human monoclonal antibody administered by subcutaneous injection that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety. PCSK9 inhibition facilitates more LDL-C clearance from the blood. Dr Mohamed . Awad. ST4 QE Gateshead. 30 . yrs. . male. PC:. 10/7 dyspnoea, productive . cough with left-sided pleuritic chest . pain and fever. . PMH:. Autism spectrum. F&W. Smokes cannabis.. I. DB00007 . Protein chemical . formula . : C. 59. H. 84. N. 16. O. 12. Protein . average . weight . : 1209.3983. Half life : . ~3 hours . Chemical name : ....